Cholecystectomy as a risk factor for oesophageal adenocarcinoma

British Journal of Surgery

Volumn 98, Issue 8, 2011, Pages 1133-1137

  Lagergren, J ^a,b   Mattsson, F ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CHOLECYSTECTOMY; COHORT ANALYSIS; ESOPHAGUS TUMOR; FEMALE; FOLLOW UP; GALLSTONE; HUMAN; MALE; MIDDLE AGED; RISK FACTOR; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHOLECYSTECTOMY; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GALLSTONES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 79960014535     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7504     Document Type: Article

References (18)

1. Kunsch S, Neesse A, Huth J, Steinkamp M, Klaus J, Adler G, et al., Increased duodeno-gastro-esophageal reflux (DGER) in symptomatic GERD patients with a history of cholecystectomy. Z Gastroenterol 2009; 47: 744-748.
2. Marshall RE, Anggiansah A, Owen WJ,. Bile in the oesophagus: clinical relevance and ambulatory detection. Br J Surg 1997; 84: 21-28. (Pubitemid 27033094)
3. Lagergren J, Bergström R, Lindgren A, Nyrén O,. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-831. (Pubitemid 29142625)
4. Hampel H, Abraham NS, El-Serag HB,. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005; 143: 199-211. (Pubitemid 41076753)
5. Parkin DM, Bray F, Ferlay J, Pisani P,. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
6. Cook MB, Chow WH, Devesa SS,. Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005. Br J Cancer 2009; 101: 855-859.
7. Freedman J, Ye W, Näslund E, Lagergren J,. Association between cholecystectomy and adenocarcinoma of the esophagus. Gastroenterology 2001; 121: 548-553. (Pubitemid 32822569)
8. Lindblad M, Ye W, Lindgren A, Lagergren J,. Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates. Ann Surg 2006; 243: 479-485.
9. Breslow NE, Day NE, (eds). Statistical Methods in Cancer Research. Volume II-The Design and Analysis of Cohort Studies. IARC Scientific Publications No. 82. International Agency for Research on Cancer: Lyons, 1987.
10. Moayyedi P, Talley NJ,. Gastro-oesophageal reflux disease. Lancet 2006; 367: 2086-2100.
11. Lacy BE, Weiser K, Chertoff J, Fass R, Pandolfino JE, Richter JE, et al., The diagnosis of gastroesophageal reflux disease. Am J Med 2010; 123: 583-592.
12. Burnat G, Majka J, Konturek PC,. Bile acids are multifunctional modulators of the Barrett's carcinogenesis. J Physiol Pharmacol 2010; 61: 185-192.
13. Gong L, Debruyne PR, Witek M, Nielsen K, Snook A, Lin JE, et al., Bile acids initiate lineage-addicted gastroesophageal tumorigenesis by suppressing the EGF receptor-AKT axis. Clin Transl Sci 2009; 2: 286-293.
14. Hong J, Behar J, Wands J, Resnick M, Wang LJ, Delellis RA, et al., Bile acid reflux contributes to development of esophageal adenocarcinoma via activation of phosphatidylinositol-specific phospholipase Cgamma2 and NADPH oxidase NOX5-S. Cancer Res 2010; 70: 1247-1255.
15. Hong J, Behar J, Wands J, Resnick M, Wang LJ, DeLellis RA, et al., Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma. Gut 2010; 59: 170-180.
16. Dvorak K, Watts GS, Ramsey L, Holubec H, Payne CM, Bernstein C, et al., Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma. Am J Gastroenterol 2009; 104: 302-309.
17. Yen CJ, Izzo JG, Lee DF, Guha S, Wei Y, Wu TT, et al., Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma. Cancer Res 2008; 68: 2632-2640. (Pubitemid 351556260)
18. Song S, Guha S, Liu K, Buttar NS, Bresalier RS,. COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma. Gut 2007; 56: 1512-1521. (Pubitemid 350033188)